Hybrid histidine kinases and antifungal warfare in thermal dimorphic fungi
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.01225-25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Frances S Faguy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA. Hauptthemen laut MEDLINE: Antifungal Agents, Histidine Kinase, Protein Kinases, Coccidioides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH HHS.
Abstract (Originalsprache)
Thermal dimorphic fungal pathogens are fungi that infect humans, often through the inhalation of asexual conidia, and which transition from hyphae to yeast in the human body. These fungi cause severe or chronic mycoses and are typically treated with azoles or amphotericin B. Ambruticin, a polyketide antifungal, shows promise as an alternative therapy. It targets hybrid histidine kinases (HHKs), which are fungal-specific proteins essential for osmoregulation and parasitic morphology and are conserved across thermal dimorphic species. Targeting HHKs suggests that ambruticin may therapeutically treat infections from multiple fungi without causing mechanism-based toxicity. We explore ambruticin’s potential to effectively treat these fungal infections without major adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA.
- Department of Chemistry, University of Colorado, Boulder, Colorado, USA.
ORCID-Profile: Frances S Faguy, Bridget M Barker
Förderung
- NIAID NIH HHS
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- NIH HHS
Zitieren
APA
Faguy, F. S., Walczak, M., & Barker, B. M. (2026). Hybrid histidine kinases and antifungal warfare in thermal dimorphic fungi. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01225-25
Vancouver
Faguy FS, Walczak M, Barker BM. Hybrid histidine kinases and antifungal warfare in thermal dimorphic fungi. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01225-25
BibTeX
@article{Faguy2026,
author = {Faguy, Frances S and Walczak, Maciej and Barker, Bridget M},
title = {Hybrid histidine kinases and antifungal warfare in thermal dimorphic fungi},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.01225-25}
}
EUVIMED